Eptinezumab improved patient-reported outcomes and quality of life in patients with migraine and prior preventive treatment failures.

Peter J Goadsby Barbanti PieroGiorgio LambruAnders EttrupCecilie Laurberg ChristoffersenMette Krog JosiassenRavinder PhulBjørn Sperling

Published in: European journal of neurology (2022)

Patients with two to four prior preventive treatment failures receiving eptinezumab vs placebo reported greater improvements in well-being, quality of life, , and most bothersome symptoms compared to placebo.

Keyphrases

patient reported outcomes
randomized controlled trial
clinical trial
combination therapy
phase iii